DECLARATION UNDER SUBSECTION 196B(6)
OF THE VETERANS’ ENTITLEMENTS ACT 1986
The Repatriation Medical Authority (the Authority), under subsection 196B(6) of the Veterans' Entitlements Act 1986 (the Act), makes the following declaration in respect of the investigation concerning xerostomia notified in the Commonwealth of Australia Gazette of 13 March 2018.
The Authority is of the view that xerostomia is a sign or symptom of other diseases or exposures, rather than a disease in its own right. The Authority declares that it does not propose to make a Statement of Principles concerning xerostomia, for the purposes of subsection 196B(2) or (3) of the Act, for the reason that the Authority formed the view that xerostomia is not a "disease" as defined in section 5D of the Act.
The Common Seal of the ) Repatriation Medical Authority ) was affixed at the direction of: ) | |
| PROFESSOR NICHOLAS SAUNDERS AO CHAIRPERSON 26 / 10 / 2018 |
Overview
The Veterans' Entitlements Act 1986 was enacted to provide a framework for the administration of veterans' benefits and services, ensuring that veterans and their families receive appropriate support and compensation for disabilities and diseases incurred during their service. The Act was introduced by the Australian Parliament to address the need for a structured approach to the entitlements of veterans, ensuring that their health and welfare needs are adequately met. The Repatriation Medical Authority, acting under the provisions of the Act, has made a declaration concerning xerostomia, determining that it is not to be considered a distinct disease but rather a symptom associated with other conditions. This declaration was made to clarify the scope of the Act, specifically in relation to the types of conditions that can be recognised for the purposes of veterans' benefits. The policy objective behind this declaration is to ensure that the benefits system remains focused on genuine diseases and conditions, maintaining the integrity and effectiveness of the support provided to veterans.
Scope and Application
The Veterans' Entitlements Act 1986 applies to veterans and their families, encompassing their health, disability, and other entitlements. This Act provides a legislative framework for the assessment, determination, and payment of benefits and services to eligible veterans, their partners, and dependent children. The declaration issued by the Repatriation Medical Authority under subsection 196B(6) pertains specifically to the investigation into xerostomia, clarifying its status as a symptom rather than a disease in its own right. This determination impacts the scope of entitlements that may be claimed under the Act. Geographically, the Act operates on a Commonwealth level, affecting all eligible veterans and their families within Australia, including its territories. The exclusion of xerostomia from the Act's definition of "disease" means that it will not be the subject of a Statement of Principles, thereby restricting the application of the Act in this specific context. The Authority's decision extends the application of the Act by excluding xerostomia from its purview, while the Act's broad scope ensures that it continues to cover a wide range of veterans' health conditions and related entitlements.
Key Provisions
The key provisions of the declaration under subsection 196B(6) of the Veterans' Entitlements Act 1986 (the Act) pertain to the Repatriation Medical Authority's (the Authority) decision regarding xerostomia. According to subsection 196B(6), the Authority has declared that it does not propose to make a Statement of Principles concerning xerostomia, as it considers xerostomia to be a sign or symptom of other diseases or exposures, rather than a disease in its own right (subsection 196B(2) and (3)). This decision is based on the Authority’s interpretation of xerostomia in the context of the definition of "disease" provided in section 5D of the Act.
The Authority’s declaration imposes certain obligations on itself and potentially on other parties involved in the adjudication of veterans' entitlements. Firstly, the Authority must ensure that its decision-making process is thorough and based on a comprehensive understanding of medical conditions and their classifications. This involves assessing whether xerostomia meets the criteria to be considered a standalone disease. Secondly, any party seeking to claim compensation or benefits related to xerostomia must now navigate the implications of this declaration, potentially necessitating further medical evidence or arguments to establish a link between xerostomia and another recognised disease.
There are no direct offences, penalties, or consequences for breach specified in the declaration itself. However, the implications of the Authority’s decision could indirectly affect veterans and their representatives. For instance, if a veteran's claim for benefits related to xerostomia is denied based on this declaration, the veteran or their representative may need to pursue further avenues of appeal or challenge the decision within the legal framework provided by the Act. The primary consequence, therefore, lies in the procedural and evidentiary requirements that must be met to satisfy the criteria for entitlement under the Act.
The Authority’s declaration, while not imposing explicit penalties, underscores the importance of adhering to the legislative definitions and criteria for qualifying diseases. This decision serves as a guideline for future claims and reinforces the necessity for precise medical evidence and interpretation when applying for veterans' benefits. The Authority’s role in defining and clarifying the scope of conditions covered under the Act is critical in ensuring that the benefits are administered fairly and in accordance with the legislative intent.